Law360: Has Amgen Already Won Its BPCIA Dispute With Sandoz?


By: Ron Vogel and Brian Coggio

Fish attorneys Brian Coggio and Ron Vogel recently published an article in Law360 where they discuss the Supreme Court determination “that Sandoz ‘violated’ the Biologics Price Competition and Innovation Act by failing to disclose its confidential information to Amgen. And according to the court, this violation is "unlawful" under California unfair competition law. Accordingly, has the disclosure issue been resolved?”

To read the full article, visit Law360.